Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Implementing an Automated DOE in Twin Screw Wet Granulation
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Newsmakers Q&A: BioVectra
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Parexel Announces CEO Transition
DifGen Acquires FDA-Registered Manufacturing Facility
Quotient Sciences Makes Executive Leadership Team Appointments
Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
DifGen Acquires FDA-Registered Manufacturing Facility
Samsung Life Science Fund Invests in BrickBio
Assurance of Global Pharma Supply
Upgraded Syngene Biologics Facility to Be Operational in Second Half of 2024
GeminiBio Introduces Aseptic Assurance System
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
Assurance of Global Pharma Supply
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Parexel Announces CEO Transition
Samsung Life Science Fund Invests in BrickBio
Selvita Adds Antibody Discovery and Development Capabilities
The High Five: Key Regulatory Topics for Drug Development in 2024
Pace Life Sciences Acquires New Jersey Lab
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
The High Five: Key Regulatory Topics for Drug Development in 2024
The “Hows” of Drug Shortages
SGS Lab in Fairfield, NJ Earns ISO/IEC 17025:2017 Certification
The Road Ahead for CDMOs in 2024
Never Assume!
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Almac Group
Lannett CDMO
Syngene International Ltd.
CMC Pharmaceuticals
AMERIPHARMA
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Almac Group
Lannett CDMO
Syngene International Ltd.
CMC Pharmaceuticals
AMERIPHARMA
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 25 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
Biologics, Proteins, Vaccines
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Company Blog
Conference Sessions
Content Microsite
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Contract Service Directory Companies
Solution Content Center Companies
Jubilant HollisterStier CMO
View All Buyers Guide Companies »
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Drug Development
|
Industry News
Samsung Life Science Fund Invests in BrickBio
Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
03.18.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Drug Discovery
|
Industry News
Selvita Adds Antibody Discovery and Development Capabilities
Will open a new research site in Wroclaw, Poland, with over 400 square meters of state-of-the-art labs along with all necessary infrastructure.
03.18.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Alcami and Tanvex CDMO Partner to Streamline Biologics Development and Manufacturing
Will offer clients a complete solution from bulk drug substance production through to finished drug product.
03.15.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Promotions & Moves
Nuclera Welcomes Joseph Bertelsen as Chief Commercial Officer
Bertelsen’s sales record will be instrumental to the commercial launch strategy and adoption of Nuclera’s eProtein Discovery platform.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Fill/Finish
Upgraded Syngene Biologics Facility to Be Operational in Second Half of 2024
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Microbix's Kinlytic Secures Manufacturing Partner for U.S. Market Return
Sequel Pharma executes agreement with CDMO for drug substance production.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Industry News
GeminiBio Introduces Aseptic Assurance System
Supports closed system manufacturing for cell therapies.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Drug Development
|
Industry News
Charles River, Navega Therapeutics Enter Gene Therapy Mfg. Pact
Will leverage Charles River’s off-the-shelf plasmid products, custom plasmid capabilities, and GMP-grade AAV production.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Precisio Biotix and Mayo Clinic Partner on Antibacterials
Aim to address some of the largest bacterial disease problems, particularly antibiotic resistance.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Clinical Trial Materials
Viroclinics-DDL Changes Name to Cerba Research
Fully enters into the Cerba Research brand after joining the group in 2022.
03.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
ProteoNic Biosciences Partners with Ginkgo Bioworks to Support Clients
Grants Ginkgo Bioworks’ customers access to ProteoNic's vector technology.
03.13.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Almirall and Eloxx Pharmaceuticals Enter Exclusive License agreement for ZKN-013
Almirall obtains global rights to develop and commercialize ZKN-013, including for the use in orphan dermatological diseases.
03.13.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
TekniPlex Healthcare to Debut Bioprocessing Solutions at INTERPHEX
Will highlight its biologics portfolio of solutions across upstream, downstream processing and final fill operations.
03.12.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Dassault Systèmes Accelerates R&D for CDR-Life
Partnered to study the stability of antibody-based biologics.
03.12.24
Biologics, Proteins, Vaccines
|
cGMP Manufacture
|
Facilities
Newsmakers Q&A: BioVectra
BioVectra's CSO talks about the LNP partnership with Acuitas Therapeutics and how the CDMO's new biomanufacturing center enhances it capabilities.
Marc Sauer , Biovectra Chief Science Officer
03.11.24
Biologics, Proteins, Vaccines
|
cGMP Manufacture
Biomanufacturing Equipment Trends
John Puglia of Thermo Fisher Scientific discusses industry trends and the latest advances in manufacturing equipment.
Online Exclusives
Kristin Brooks, Managing Editor, Contract Pharma
03.11.24
Biologics, Proteins, Vaccines
|
Breaking News
AstraZeneca Pledges $287M to Increase Presence in UK
Plans include a new R&D facility and the expansion of its vaccine manufacturing capabilities.
03.07.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Industry News
Johnson & Johnson Acquires Ambrx Biopharma
Deepens its pipeline of next-generation antibody drug conjugates and targeted oncologic therapeutics.
03.07.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
BioCentriq Enhances Partnership with Pluristyx
Expands collaboration to include access to Pluristyx's proprietary iPSC lines.
03.07.24
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Industry News
New ACROBiosystems Initiative to Support CGT Manufacturers
Aims to streamline the transition from research to the clinic by offering progressive reagents at each stage.
03.04.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Solid Dosage/Creams/Ointments
Nocion Therapeutics Raises $62M in Series B Funding
Proceeds will be used to evaluate the lead program, Taplucanium Dry Powder for Inhalation, in a Phase 2b study in Chronic Cough patients.
03.04.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
Eilean Therapeutics Acquires Ness Therapeutics
Ness’ non-clinical PTPN2 program has potential to improve the efficacy of cancer immunotherapy regimens.
03.04.24
Biologics, Proteins, Vaccines
|
cGMP Manufacture
Overcoming the Challenges of Automation
Navigating compliance and technological integration in biopharma dark factories.
David Shenberger, Vice President of Strategic Development, CAI
02.29.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for FNIH
Will optimize and scale the AAV therapy processes for the treatments of CNGB1 Retinitis Pigmentosa 45 and NPHP5 retinal degeneration.
02.29.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Industry News
Ginkgo Bioworks Acquires Proof Diagnostics
Expands its gene editing service offerings for its customers.
02.28.24
Biologics, Proteins, Vaccines
|
Breaking News
CordenPharma Launches LNP Starter Kits for mRNA Therapeutics
Provides researchers and developers with the essential components needed to create and optimize their own LNPs for mRNA delivery.
02.28.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
BioCina and NovaCina Partner to Provide Integrated Drug Substance & Drug Product Solutions
BioCina's clients to benefit from NovaCina's clinical and commercial fill-and-finish experience.
02.28.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Promotions & Moves
Bexion Pharmaceuticals Welcomes Dr. Tariq Arshad as Chief Medical Officer
Arshad is an oncologist with 25+ years of experience and a successful track record of strategic planning, clinical development and commercialization.
02.28.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Nona Biosciences, Boostimmune Enter ADC Alliance
To leverage Nona's Harbour Mice H2L2 platform to accelerate development of Antibody-Drug Conjugates against novel targets.
02.27.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Takeda Partners with Biological E. to Accelerate Access to Dengue Vaccine
Will enhance manufacturing capabilities to ensure a sustainable global supply of the vaccine.
02.27.24
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
|
Trials & Filings
FDA Approves AMTAGVI for Advanced Melanoma
WuXi Advanced Therapies receives approval for its Philadelphia site to begin the analytical testing and manufacture of AMTAGVI for Iovance.
02.23.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Promotions & Moves
Curia Taps Steve Lavezoli as VP of Biologics
Lavezoli to lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.
02.23.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Preclinical Outsourcing
Charles River, Wheeler Bio Partner to Accelerate Discovery to IND Submission
Agreement combines Charles River’s experience in antibody discovery services, safety, and analytics with Wheeler’s Portable CMC platform.
02.21.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
Evonik, University of Mainz Partner on Drug Delivery
Aim to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs.
02.20.24
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
Global Biologics Contract Manufacturing Market Forecasted to Grow
Expected to expand at a CAGR of ~9% during the forecast period from 2023 to 2035.
02.20.24
Biologics, Proteins, Vaccines
|
Breaking News
Ginkgo, SaponiQx Awarded $31M to Develop Next-Gen Vaccine Adjuvants
Aim to use a combination of high-throughput empirical and AI/machine learning approaches to develop novel saponin-based adjuvants.
02.16.24
Biologics, Proteins, Vaccines
Firefly Bio Debuts with $94M Series A Funding Round
Funding will support its novel platform for treating cancer by merging antibody-drug conjugates with protein degraders.
02.16.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Xyphos Biosciences & Kelonia Partner to Develop Novel Immuno-Oncology Therapeutics
Will combine Kelonia's iGPS with Xyphos' ACCEL technology to develop in vivo CAR-T Cell therapies.
02.16.24
Biologics, Proteins, Vaccines
|
Breaking News
|
cGMP Manufacture
Scinai Immunotherapeutics Names Liat Halpert Head of Business Development & Sales
Halpert brings extensive pharmaceutical sales and marketing experience and joins Scinai following 14 years at Novartis.
02.15.24
Bio News
|
Bioanalytical Services
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Laboratory Testing
Thermo Fisher Expands GMP Lab Services with Mycoplasma and Biosafety Testing
Aims to provide lab customers a comprehensive solution to help ensure safe medicines for patients.
02.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
VantAI, BMS Partner to Accelerate Molecular Glue Drug Discovery
Will leverage VantAI's geometric deep learning capabilities with Bristol Myers Squibb’s expertise in targeted protein degradation.
02.14.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Drug Discovery
|
Promotions & Moves
StromaCare Names Georges Rawadi as CEO
Rawadi brings over 20 years of experience in the pharma and biotech industry.
02.14.24
Biologics, Proteins, Vaccines
|
Breaking News
BioVaxys Acquires IP, Immunotherapeutics Platform Technology & Assets of IMV Inc.
Anticipates tremendous commercial potential with the DPX antigen delivery platform.
02.12.24
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
Cidara Therapeutics Receives $11M Milestone for European Approval of REZZAYO
Marks a significant milestone for patients who are in need of new treatment options for invasive candidiasis.
02.12.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
R&D
Orexo AB Advances Exploratory Feasibility Study with Sobi
Aims to evaluate if the AmorphOX drug delivery platform can add unique properties to one of Sobi's biomolecules.
02.12.24
Biologics, Proteins, Vaccines
CGT Sector Faces Critical Shortage of Skilled Personnel
Prof. Ivan Wall, from the University of Birmingham, shares insights on how the industry can combat the problem.
Online Exclusives
Tim Wright, Editor, Contract Pharma
02.08.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Clinical Trial Materials
|
Collaborations & Alliances
|
Drug Development
BioNTech & Autolus Partner to Advance CAR-T Therapies, Boost Pipeline Efficiency
New collaboration is aimed at advancing both companies’ autologous CAR-T programs towards commercialization, pending regulatory authorizations.
02.08.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Promotions & Moves
Tris Pharma Welcomes Michael Magee as VP, Quality and Compliance
Magee will lead and strengthen Tris Pharma’s continued development and management of quality and compliance operations.
02.08.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
Jazz Pharmaceuticals to Acquire Redx Pharma’s KRAS Inhibitor Program
Redx to receive $10M upfront; potential for up to $870M in development, regulatory and sales milestone payments plus royalties on future net sales.
02.08.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Solid Dosage/Creams/Ointments
Abzena Launches LabZient Analytical Platform
Aims to streamline the assessment and validation of large molecules, thereby reducing drug development timelines and resource costs.
02.08.24
Breaking News
Parexel Announces CEO Transition
DifGen Acquires FDA-Registered Manufacturing Facility
Quotient Sciences Makes Executive Leadership Team Appointments
Plenaries Discuss AI and Next-Gen Modality Development at AAPS NBC
SCHOTT Pharma Invests $371M in U.S. Prefillable Syringe Mfg. Facility
View Breaking News >
CURRENT ISSUE
March 2024
Implementing an Automated DOE in Twin Screw Wet Granulation
Sustainable Pharmaceutical Packaging
Pre-filled Syringe Packaging Trends
Liquid Pharmaceutical Filling: Small, Smaller, Micro Batches
Newsmakers Q&A: BioVectra
Multi-particulate Formulations – Tablets or Capsules?
Manufacturing Equipment Trends
OSD Outsourcing: Savvy CMOs Hone Skills as Complex APIs Fuel Demand
Catalent Acquisition by Novo Holdings: Evolution of the Industry(?)
The Road Ahead for CDMOs in 2024
View More >